From the Early/Expanded Access Committee
Now available in 11 states (more sites expected): Expanded Access to MDV3100 in Patients With Progressive Castration-Resistant
Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
No placebo - No cost for MDV3100/enzalutamide (check with trial site for any other costs)Basic Eligibility Criteria:- CRPC/HRPC - on hormone therapy with progressive disease
- Metastatic
- NO small cell or neuroendocrine features
- Previously treated with Taxotere (docetaxel)
- No brain metastases
- HGB 9.0 or higher
- No history of stroke or seizure
- No significant cardiovascular disease
If you think you fit the above criteria, contact one of the sites below for further criteria and screening.
Alaska
Alaska Clinical Research Center, LLC
Contact: Robin Adams (907) 276-1455
Anchorage, Alaska 99508
Arizona
Pinnacle Oncology/Hematology
Contact: Sherril Bierman (480) 278-8804
Scottsdale, AZ 85258
California
Prostate Oncology Specialists
Contact: Jennifer Leung (310) 827-7707
Marina del Rey, CA 90292
Dr Ronald Yanagihara
Contact: Katrina or Lara (408) 847-6194
Gilroy, CA 95020
Georgia
PeachTree Hematology Oncology Consultants
Contact: Ann Johnston (678) 298-3241
Atlanta, GA
Illinois
Illinois Cancer CareContact: Carrie Margus (390) 243-36271
Peoria, IL 61615
Indiana
Investigative Clinical Research of Indiana LLC
Contact: Leslie Weitman (317) 716-0323
Indianapolis, IN 46260
Mississippi
Jackson Oncology Associates PLLC
Contact: Teresa Davis (601) 974-5547
Jackson, Mississippi 39202
New Hampshire
New Hampshire Oncology Hematology PA
Contact: Margaret White (603) 224-2556 x1323
Hooksett, New Hampshire, 03106
New York
Accumed Research Associates
Contact: Tammi Allegra (516) 746-2190
Garden City, New York, 11530
North Carolina
Cancer Centers of North Carolina
Contact: Julia Berry (919) 781-7070
Raleigh, North Carolina 27607
South Carolina
Charleston Hematology Oncology Associates, PA
Contact: Deborah McNeal (843) 266-2540
Charleston, South Carolina, 29414
Carolina Urologic Research Center
Contact: Tabitha Joyner (843) 449-1010 x228
Myrtle Beach, South Carolina, 29572
Tennessee
The Jones Clinic, PC
Contact: Lori Lynch (901) 685-5969 x322Germantown, TN 38138
Virginia
Virginia Oncology Associates
Contact: Wendi Gobhardt (757) 213-5813
Norfolk, VA, 23502
Enrollment Tip - It often takes a few weeks to complete the enrollment and screening process for an expanded access trial. You may be able to speed up this process by supplying the clinical trial nurse with your own medical records, which may relieve him/her from trying to obtain them from another clinic. Factor all of this into your decisions. As always, discuss with your physician(s).
Jan Manarite
Early/Expanded Access Committee
PCRI Senior Educational Facilitator
(239) 395-0995 Direct
The PROSTATE CANCER RESEARCH INSTITUTE is a registered non-profit organization. Visit us at www.PCRI.org
I am a prostate cancer researcher and advocate, not a medical professional. Information I share with you is to help expand your knowledge for discussion with your own physicians and should not be considered actual medical advice.